| Comparison of DNA and mRNA vaccines against cancer Z Jahanafrooz, B Baradaran, J Mosafer, M Hashemzaei, T Rezaei, ... Drug discovery today 25 (3), 552-560, 2020 | 151 | 2020 |
| microRNA-181 serves as a dual-role regulator in the development of human cancers T Rezaei, M Amini, ZS Hashemi, B Mansoori, S Rezaei, H Karami, ... Free Radical Biology and Medicine 152, 432-454, 2020 | 79 | 2020 |
| MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer M Hejazi, E Baghbani, M Amini, T Rezaei, A Aghanejad, J Mosafer, ... Journal of cellular biochemistry 121 (2), 1388-1399, 2020 | 45 | 2020 |
| "Strategies in DNA vaccine for Melanoma cancer" AM T Rezaei, E Davoudian, S Khalili, M Amini, M Hejazi, M de la Guardia Pigment Cell & Melanoma Research, 2020 | 36* | 2020 |
| Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials T Rezaei, S Khalili, B Baradaran, J Mosafer, S Rezaei, A Mokhtarzadeh, ... Journal of Controlled Release 316, 116-137, 2019 | 30 | 2019 |
| microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis T Rezaei, M Hejazi, B Mansoori, A Mohammadi, M Amini, J Mosafer, ... European Journal of Pharmacology 888, 173483, 2020 | 28 | 2020 |
| ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis N Bidar, T Rezaei, M Amini, A Jebelli, A Mokhtarzadeh, B Baradaran Experimental and Molecular Pathology 121, 104663, 2021 | 7 | 2021 |
Amir Ali MokhtarzadehAssistant Professor of Pharmaceutical Biotechnology,Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
